Winton Group LTD Axsome Therapeutics, Inc. Transaction History

Winton Group LTD

$1.37 Billion
Q2 2024

A detailed history of Winton Group LTD transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Winton Group LTD holds 8,823 shares of AXSM stock, worth $798,569. This represents 0.05% of its overall portfolio holdings.

Number of Shares

8,823

Previous 3,438 156.63%

Holding current value

$798,569

Previous $274,000 159.12%

% of portfolio

0.05%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$65.72 - $80.5 $353,902 - $433,492	5,385 Added 156.63%	8,823 $710,000
Q1 2024 May 14, 2024	BUY	$69.39 - $97.64 $238,562 - $335,686	3,438 New	3,438 $274,000
Q2 2023 Aug 14, 2023	SELL	$58.41 - $90.35 $447,128 - $691,629	-7,655 Reduced 59.65%	5,179 $372,000
Q1 2023 May 12, 2023	BUY	$58.39 - $75.0 $19,151 - $24,600	328 Added 2.62%	12,834 $791,000
Q4 2022 Feb 14, 2023	SELL	$39.94 - $79.72 $58,152 - $116,072	-1,456 Reduced 10.43%	12,506 $964,000
Q3 2022 Nov 10, 2022	SELL	$36.06 - $69.85 $138,722 - $268,712	-3,847 Reduced 21.6%	13,962 $623,000
Q2 2022 Aug 10, 2022	BUY	$21.74 - $46.75 $31,849 - $68,488	1,465 Added 8.96%	17,809 $682,000
Q1 2022 May 11, 2022	BUY	$23.7 - $41.39 $55,339 - $96,645	2,335 Added 16.67%	16,344 $676,000
Q4 2021 Feb 10, 2022	BUY	$30.7 - $43.36 $132,286 - $186,838	4,309 Added 44.42%	14,009 $529,000
Q3 2021 Oct 28, 2021	SELL	$19.91 - $68.26 $61,163 - $209,694	-3,072 Reduced 24.05%	9,700 $320,000
Q2 2021 Aug 10, 2021	BUY	$50.63 - $73.5 $106,879 - $155,158	2,111 Added 19.8%	12,772 $862,000
Q1 2021 Jul 21, 2021	BUY	$55.91 - $81.44 $218,104 - $317,697	3,901 Added 57.71%	10,661 $604,000
Q4 2020 Feb 12, 2021	SELL	$66.31 - $86.52 $1.53 Million - $2 Million	-23,082 Reduced 77.35%	6,760 $551,000
Q3 2020 Oct 30, 2020	BUY	$68.34 - $85.84 $123,490 - $155,112	1,807 Added 6.45%	29,842 $2.13 Million
Q2 2020 Aug 05, 2020	SELL	$49.87 - $98.69 $62,536 - $123,757	-1,254 Reduced 4.28%	28,035 $2.31 Million
Q1 2020 May 11, 2020	SELL	$41.2 - $101.31 $8.17 Million - $20.1 Million	-198,237 Reduced 87.13%	29,289 $1.72 Million
Q4 2019 Feb 13, 2020	BUY	$16.71 - $106.24 $3.8 Million - $24.2 Million	227,526 New	227,526 $23.5 Million

Others Institutions Holding AXSM

# of Institutions

288

Shares Held

40.4M

Call Options Held

365K

Put Options Held

428K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.88B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account